Clinical Trial Update: Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetics study of a generic lopinavir/ritonavir regimen in pregnant women with HIV completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• generic lopinavir/ritonavir (lopinavir/ritonavir)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV Infections | Phase 2 | Status: COMPLETED